Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 76351-76400 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT05549752
Flecainide Versus Amiodarone in the Cardioversion of Paroxysmal Atrial Fibrillation at the Emergency Department, in Patients With Coronary Artery Disease Without Residual Ischemia
PHASE3
Recruiting
80 participants
Started: Mar 24, 2023 · Completed: Jan 30, 2026
2 conditions
3 sponsors
3 locations
NCT05787652
Adults Regulating Their Weight Everyday With Mobile Internet Support
NA
Active, not recruiting
1,294 participants
Started: Mar 24, 2023 · Completed: Mar 23, 2025
1 condition
2 sponsors
1 location
NCT05765370
LDL Cholesterol TARGETs in OLDer Patients (Age≥75 Years) With ASCVD (TARGET OLD)
NA
Recruiting
4,200 participants
Started: Mar 24, 2023 · Completed: Dec 24, 2026
3 conditions
1 sponsor
1 location
NCT05801263
ctDNA Methylation for Epithelial Ovarian Cancer
N/A
Recruiting
5,000 participants
Started: Mar 24, 2023 · Completed: Mar 24, 2026
8 conditions
1 sponsor
1 location
NCT06086574
Developing Circulating and Imaging Biomarkers Towards Personalised Radiotherapy in Lung Cancer
N/A
Recruiting
80 participants
Started: Mar 24, 2023 · Completed: Sep 24, 2025
1 condition
2 sponsors
1 location
NCT06367920
Multicenter Study on Rehabilitation Medical Data for Pediatric Big Brain Development
N/A
Recruiting
2,000 participants
Started: Mar 23, 2023 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT05389774
DOLCE: Determining the Impact of Optellum's Lung Cancer Prediction Solution
N/A
Recruiting
2,000 participants
Started: Mar 23, 2023 · Completed: Aug 31, 2025
4 conditions
2 sponsors
10 locations
NCT05616273
Stimulated Glucagon As a Biomarker of Hypoglycemic Risk in Type 1 Diabetes
N/A
Recruiting
75 participants
Started: Mar 23, 2023 · Completed: Sep 30, 2025
2 conditions
2 sponsors
1 location
NCT06380387
Whole Body Metabolism in Children Before and After Treatment of CNS Tumor
NA
Recruiting
30 participants
Started: Mar 23, 2023 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT05848570
Keeping it LITE: Exploring HIV Risk in Vulnerable Youth With Limited Interaction and Digital Health Intervention
N/A
Recruiting
6,000 participants
Started: Mar 23, 2023 · Completed: May 31, 2027
2 conditions
2 sponsors
1 location
NCT05416060
Dulce Digital 2.0 - Innovative Diabetes Self-Management in the Digital Age
NA
Recruiting
150 participants
Started: Mar 23, 2023 · Completed: Jan 31, 2026
1 condition
1 sponsor
2 locations
NCT06135597
Immune Regulation in Chronic Aspergillus Infection After COVID-19 Infection
N/A
Recruiting
100 participants
Started: Mar 23, 2023 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT05736679
EaveTubes for Vector Control
NA
Active, not recruiting
1,870 participants
Started: Mar 23, 2023 · Completed: Dec 31, 2025
1 condition
3 sponsors
1 location
NCT06673875
Assessment of Pelvic Floor Muscle Training Using Modern Conservative Methods in the Therapy of Stress Urinary Incontinence
NA
Recruiting
90 participants
Started: Mar 23, 2023 · Completed: May 31, 2026
1 condition
1 sponsor
1 location
NCT05817929
Angiopoietin and Adverse Outcomes in Cardiac Surgery
NA
Recruiting
200 participants
Started: Mar 23, 2023 · Completed: Apr 30, 2027
2 conditions
1 sponsor
1 location
NCT05669430
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
PHASE1/PHASE2
Recruiting
365 participants
Started: Mar 23, 2023 · Completed: Sep 5, 2027
7 conditions
2 sponsors
13 locations
NCT05837260
Investigating Utility of ctDNA and Tumour Evolution in Advanced Thyroid Cancer
N/A
Recruiting
120 participants
Started: Mar 23, 2023 · Completed: Feb 7, 2027
1 condition
1 sponsor
1 location
NCT05781321
Short Course Radiotherapy for the Treatment of Patients With Glioblastoma, SAGA Study
PHASE2
Active, not recruiting
170 participants
Started: Mar 23, 2023 · Completed: Jul 2, 2028
1 condition
1 sponsor
8 locations
NCT05689879
Evaluation of TNF-alpha Antagonists (Infliximab) Withdrawal in Sarcoidosis
PHASE3
Recruiting
90 participants
Started: Mar 23, 2023 · Completed: Mar 31, 2027
1 condition
1 sponsor
1 location
NCT06187012
Hypertension Explored in Long-term Postpartum Follow-up in Later Life
N/A
Recruiting
200 participants
Started: Mar 23, 2023 · Completed: Nov 1, 2042
4 conditions
1 sponsor
1 location
NCT05780307
IMM2520, a PD-L1 and CD47 Bispecific Antibody in Patients With Advanced Solid Tumors
PHASE1
Recruiting
48 participants
Started: Mar 23, 2023 · Completed: Oct 26, 2025
6 conditions
2 sponsors
1 location
NCT05725720
Role of the Gut Microbiome in the Outcome of Diffuse Large B-Cell Lymphoma Patients Treated With CAR-T Cell Therapy
N/A
Recruiting
90 participants
Started: Mar 23, 2023 · Completed: Dec 31, 2027
1 condition
3 sponsors
1 location
NCT05687149
Defining the Natural History of Squamous Cell Carcinoma in Fanconi Anemia
N/A
Recruiting
200 participants
Started: Mar 23, 2023 · Completed: Dec 31, 2035
2 conditions
1 sponsor
1 location
NCT05552443
A Study of Intrathecal Hydromorphone for Pediatric Idiopathic Scoliosis Repair
PHASE4
Recruiting
40 participants
Started: Mar 23, 2023 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT05709288
Gene Therapy for Hemophilia B Patients Aged 12-18 Years Old
PHASE1
Recruiting
9 participants
Started: Mar 23, 2023 · Completed: Nov 30, 2035
1 condition
1 sponsor
1 location
NCT05819476
Boosting Open-Label Placebo Effects in Acute Induced Pain in Healthy Adults
NA
Recruiting
141 participants
Started: Mar 23, 2023 · Completed: Jun 30, 2025
1 condition
1 sponsor
1 location
NCT05689567
Focus-out Glasses on Emmetropization in Chinese Children
NA
Active, not recruiting
160 participants
Started: Mar 23, 2023 · Completed: Mar 31, 2025
3 conditions
1 sponsor
1 location
NCT05626114
A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251
PHASE2
Recruiting
60 participants
Started: Mar 23, 2023 · Completed: Mar 1, 2031
1 condition
1 sponsor
15 locations
NCT05440708
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
PHASE1/PHASE2
Recruiting
178 participants
Started: Mar 23, 2023 · Completed: Jun 28, 2027
1 condition
1 sponsor
21 locations
NCT05767047
A Study of Apremilast in Children With Oral Ulcers Associated With Behçet's Disease or Juvenile Psoriatic Arthritis
PHASE3
Recruiting
48 participants
Started: Mar 23, 2023 · Completed: Mar 17, 2036
2 conditions
1 sponsor
7 locations
NCT05786040
Tafasitamab and Rituximab for Front-Line Treatment of Post-Transplant Lymphoproliferative Disorder
PHASE2
Recruiting
28 participants
Started: Mar 23, 2023 · Completed: Dec 31, 2025
2 conditions
1 sponsor
3 locations
NCT05651828
Adaptive Therapy of Vismodegib in Advanced Basal Cell Carcinoma
EARLY_PHASE1
Recruiting
34 participants
Started: Mar 23, 2023 · Completed: Dec 31, 2029
1 condition
2 sponsors
1 location
NCT06760221
Safety and Efficacy of Preoperative SBRT and Radical Surgery for Soft Tissue Sarcoma of Extremities
NA
Recruiting
20 participants
Started: Mar 23, 2023 · Completed: Dec 31, 2029
3 conditions
2 sponsors
1 location
NCT05805826
To Understand the Safety and Effects of a C. Difficile Vaccine With New Adds-Ons That Will Be Given to Healthy Adults
PHASE1/PHASE2
Active, not recruiting
689 participants
Started: Mar 23, 2023 · Completed: Aug 28, 2028
1 condition
1 sponsor
25 locations
NCT06040203
Leukocyte-rich PRP or Leukocyte-free PRP vs Placebo in the Treatment of Epicondylitis
NA
Recruiting
240 participants
Started: Mar 23, 2023 · Completed: Mar 31, 2027
1 condition
1 sponsor
1 location
NCT05652868
Clinical Study of Antibody-Drug Conjugate MYTX-011 in Subjects With Non-Small Cell Lung Cancer
PHASE1
Recruiting
250 participants
Started: Mar 23, 2023 · Completed: Dec 31, 2027
7 conditions
1 sponsor
55 locations
NCT05413551
Point-of-care Pharmacogenomic Testing to Optimize Isoniazid Dosing for Tuberculosis Prevention
PHASE1
Recruiting
72 participants
Started: Mar 23, 2023 · Completed: Oct 31, 2025
2 conditions
4 sponsors
1 location
NCT05642325
Vamikibart in Participants With Uveitic Macular Edema
PHASE3
Active, not recruiting
256 participants
Started: Mar 23, 2023 · Completed: Dec 14, 2025
1 condition
1 sponsor
94 locations
NCT05778253
The Role of ctDNA Testing Plus AI-based Pathology in Resectable LSCC
N/A
Recruiting
50 participants
Started: Mar 23, 2023 · Completed: Sep 23, 2029
1 condition
2 sponsors
1 location
NCT05781074
Cryoablation Combined With Sintilimab Plus Lenvatinib in Patients With Immune Checkpoint Inhibitor Previously Treated Advanced Biliary Tract Cancer (CASTLE-08)
PHASE2
Recruiting
25 participants
Started: Mar 23, 2023 · Completed: Dec 30, 2025
1 condition
1 sponsor
1 location
NCT05735379
Impact in Older Adults of Reducing Anticholinergic and Sedative Rx Burden on Physical Function Measured by Wearables
PHASE4
Recruiting
182 participants
Started: Mar 23, 2023 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT05317000
5-Azacytidine and/or Nivolumab in Resectable HPV-Associated HNSCC
PHASE2
Recruiting
50 participants
Started: Mar 23, 2023 · Completed: Feb 28, 2027
1 condition
2 sponsors
1 location
NCT05714202
A Study of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guérin (BCG) in Participants With BCG-naïve High-risk Non-muscle Invasive Bladder Cancer (HR-NMIBC)
PHASE3
Active, not recruiting
1,135 participants
Started: Mar 23, 2023 · Completed: Sep 18, 2029
1 condition
1 sponsor
240 locations
NCT06047964
SeQuent ® Please CIS for the Treatment of INtracranial Atherosclerotic Stenosis
NA
Active, not recruiting
281 participants
Started: Mar 23, 2023 · Completed: Jan 23, 2025
2 conditions
1 sponsor
9 locations
NCT05323955
Secondary BRain Metastases Prevention After Isolated Intracranial Progression on Trastuzumab/Pertuzumab or T-DM1 in Patients With aDvanced Human Epidermal Growth Factor Receptor 2+ brEast Cancer With the Addition of Tucatinib
PHASE2
Active, not recruiting
48 participants
Started: Mar 23, 2023 · Completed: Jul 31, 2026
3 conditions
2 sponsors
8 locations
NCT05633875
Multimodal Imaging Signatures of the Biological Mechanisms Underlying Neurodegeneration in Multiple Sclerosis
N/A
Recruiting
80 participants
Started: Mar 23, 2023 · Completed: Apr 25, 2025
1 condition
1 sponsor
1 location
NCT05765864
Self-harm Behaviour Among the Most At-risk Adolescents
N/A
Recruiting
400 participants
Started: Mar 23, 2023 · Completed: Oct 31, 2025
6 conditions
4 sponsors
2 locations
NCT05855902
Art Therapy in an Intensive OCD Program
N/A
Enrolling by invitation
100 participants
Started: Mar 23, 2023 · Completed: Mar 30, 2026
1 condition
1 sponsor
1 location
NCT06056362
Comparison of Al18F-NOTA-LM3 With 68Ga-DOTATATE and 68Ga-NODAGA-LM3 PET/CT in Patients With Well-differentiated Neuroendocrine Tumors
PHASE1/PHASE2
Recruiting
80 participants
Started: Mar 23, 2023 · Completed: Mar 27, 2025
1 condition
1 sponsor
1 location
NCT05649852
Anxiolytic Effects of Socio-aesthetics in Cancer Patients Undergoing Chemotherapy
NA
Recruiting
192 participants
Started: Mar 23, 2023 · Completed: Sep 30, 2025
1 condition
2 sponsors
1 location
Previous
1
More pages
1525
1526
1527
1528
1529
1530
1531
More pages
2369
Next